Evoke Pharma (EVOK) announced the appointment of Ben Smeal to serve on the Company’s Board of Directors effective October 18, 2024. This appointment fulfills a condition set as part of the company’s most recent financing by Nantahala Capital Management. Before transitioning to full-time private investing, Smeal held roles at Willett Advisors, the family office of Michael R. Bloomberg, and Kenmare Management.